XML 31 R20.htm IDEA: XBRL DOCUMENT v3.21.1
Revision to Prior Period Financial Statements (Tables)
3 Months Ended
Mar. 31, 2021
New Accounting Pronouncements And Changes In Accounting Principles [Abstract]  
Summary of Post IPO Balance Sheet

The Company concluded that the misstatement was not material to the Post-IPO Balance Sheet and the misstatement had no material impact to any prior interim period. The effect of the revisions to the Post-IPO Balance Sheet is as follows:

 

 

 

As of March 4, 2021

 

 

 

As Previously

Reported

 

 

Revision

Adjustments

 

 

As Revised

 

Balance Sheet

 

 

 

 

 

 

 

 

 

 

 

 

Total assets

 

$

346,880,911

 

 

$

-

 

 

$

346,880,911

 

Liabilities  and shareholders’ equity

 

 

 

 

 

 

 

 

 

 

 

 

Total current liabilities

 

$

489,940

 

 

$

-

 

 

$

489,940

 

Deferred underwriting commissions

 

 

12,075,000

 

 

 

-

 

 

 

12,075,000

 

Derivative warrant liabilities

 

 

-

 

 

 

13,205,750

 

 

 

13,205,750

 

Total liabilities

 

 

12,564,940

 

 

 

13,205,750

 

 

 

25,770,690

 

Class A ordinary shares, $0.0001 par value; shares subject to possible redemption

 

 

329,315,970

 

 

 

(13,205,750

)

 

 

316,110,220

 

Shareholders’ equity

 

 

 

 

 

 

 

 

 

 

 

 

Prefered shares- $0.0001 par value

 

 

-

 

 

 

-

 

 

 

-

 

Class A ordinary shares - $0.0001 par value

 

 

157

 

 

 

132

 

 

 

289

 

Class B ordinary shares - $0.0001 par value

 

 

863

 

 

 

-

 

 

 

863

 

Additional paid-in-capital

 

 

5,040,797

 

 

 

502,318

 

 

 

5,543,115

 

Accumulated deficit

 

 

(41,816

)

 

 

(502,450

)

 

 

(544,266

)

Total shareholders’ equity

 

 

5,000,001

 

 

 

-

 

 

 

5,000,001

 

Total liabilities and shareholders’ equity

 

$

346,880,911

 

 

$

-

 

 

$

346,880,911